Iovance Biotherapeutics Inc. Common Stock vs Smurfit WestRock plc Ordinary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B), while Smurfit WestRock plc Ordinary Shares trades at $41.29 (market cap $21.74B). The key difference: Smurfit WestRock plc Ordinary Shares is far larger — about 3.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and Smurfit WestRock plc Ordinary Shares pays a 4.36% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Smurfit WestRock plc Ordinary Shares for 0 Days on average.
| IOVA | SW | |
|---|---|---|
Market Cap | $6.04B | $21.74B |
Volume | 14,805,993 | 5,178,763 |
Sector | Health | Consumer Cyclical |
52-Week High | $14.82 | $51.84 |
52-Week Low | $1.81 | $32.79 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $35.23B |
Dividend Yield | — | 4.36% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Smurfit WestRock plc is an Ireland-headquartered packaging company that manufactures corrugated containers and consumer packaging from containerboard and paperboard, operating mills, converting plants, and recycling facilities across more than 40 countries.
Read more on SW →